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AbstrAct
The aim of this study was to compare the effec-
tiveness of dexamethasone administration follow-
ing arthrocentesis of the temporomandibular joint 
(TMJ) with a placebo (saline). Twenty-eight par-
ticipants with TMJ arthralgia were randomly 
assigned to two groups of a parallel double-blind 
RCT. In both groups, an arthrocentesis procedure 
was carried out. In one group, the procedure was 
followed by the administration of a single-dose 
intra-articular dexamethasone. In the other group, 
saline was administered as a control. Follow-up 
visits were scheduled after 1, 3, and 24 weeks. 
During each visit, TMJ pain (on a 100-mm VAS) 
and jaw stiffness (mouth opening in mm) were 
scored. In the statistical analysis, generalized esti-
mating equation (GEE) models showed no differ-
ences between the two study groups, although pain 
and jaw stiffness were both reduced over 24 
weeks. In conclusion, intra-articular dexametha-
sone following arthrocentesis did not improve the 
procedure’s effect in patients presenting with TMJ 
arthralgia (ClinicalTrials.gov number CT01275014).
KEY WOrDs: TMD, pain, arthralgia, corticoste-
roids, lavage, RCT.
IntrODuctIOn
Orofacial pain can be severe and includes cases of intractable pain as well as acute pain. The most frequent source of orofacial pain is den-
tal disease. Among other sources are musculoskeletal, vascular, neurovascu-
lar, and neuropathic disorders. Musculosketetal sources of orofacial pain are 
comprised of joint disorders and muscle disorders, although joint and muscle 
symptoms frequently occur simultaneously. Pain arising from joint disorders 
is termed ‘arthralgia’.
Causes of arthralgia would include mechanical nerve compression second-
ary to articular disc displacement (Johansson et al., 1990), neurogenic inflam-
mation (Sessle, 1999) secondary to intra-articular changes and synovitis, 
adhesions, or arthritis. Historically, the displaced disc was considered the 
primary cause of arthralgia, but the observations that arthroscopy and arthro-
centesis of the superior joint compartment reduce or eliminate pain in patients 
with a permanently displaced disc, without repositioning the displaced disc, 
have disproved the displaced disc as the cause of arthralgia (Stegenga, 2001). 
Another possible cause for arthralgia may be mechanical trauma from repeti-
tive extreme loading (i.e., habitual jaw-clenching, bruxism), causing transient 
hypoxia (Shirakura et al., 2010). The hypoxia may create oxygen-derived free 
radicals that activate a variety of biochemical changes, leading to arthralgia.
The current treatment modalities focus on alleviating pain and improving 
function. Arthrocentesis is a minimally invasive procedure aimed at removing 
inflammatory and pain mediators from the joint cavity solely by the intra-
articular flow of saline (Moses et al., 1989; Nitzan and Price, 2001). In addi-
tion to arthrocentesis, corticosteroids are commonly added in an attempt to 
further reduce pain and jaw stiffness (van Oosterhout et al., 2006). 
Corticosteroids modify the vascular response during the inflammatory pro-
cess and inhibit enzymes and the actions of inflammatory cells. Their use in 
the TMJ remains controversial with regard to their efficacy and unknown 
duration (Wenneberg et al., 1991).
The aim of the current study was to test the additional effect on pain and 
jaw stiffness of a short-acting corticosteroid (dexamethasone) following an 
arthrocentesis procedure in the TMJ.
MEthODs
Participants
Patients referred to the Department of Oral and Maxillofacial Surgery of the 
University Medical Centre Groningen, with pain in front of the ear or the TMJ 
area, were asked to participate. All were examined for crepitation and disc 
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displacements by means of anamnesis, the presence of articular 
sounds, and deviation/deflection in full-mouth opening. 
Radiographic images (panoramic, transpharyngeal, and tran-
scranial) were made to visualize the existence of tissue altera-
tions.
Inclusion criterion were
(I) History positive for all of the following:
(a) In the preceding month, ongoing pain in the face, 
jaw, temple, in front of the ear, or in the ear, and:
(b) Pain provocation on active mandibular movement 
to all directions (opening, right or left lateral 
movements, or protrusive).
(c) Provocation of the pain on palpation of the lateral 
pole or around the lateral pole of the condyle.
and
(II) Complete remission of the reported pain 10 min after 
the administration of local intra-articular anesthesia [by 
injection of 0.1 mL articaine 40 mg/mL (Ultracain 
forte, Aventis Pharma, Hoevelaken, The Netherlands) 
into the upper joint cavity] (Tjakkes et al., 2007).
Exclusion criteria were:
- past history of open surgery in the affected joint,
- known polyarthritis or rheumatoid arthritis,
- age under 18 yrs,
- ankylosis of the TMJ, and
- self-reported pregnancy.
All participants were informed about their condition and 
were prescribed Ibuprofen 600 mg three times a day for a seven-
day period. After 2 wks, a recall visit was scheduled. Patients 
who appeared to be symptom-free during that recall were 
excluded from the study.
Full oral and written information about the treatment and the 
purpose of the study was provided to all participants. All partici-
pants signed informed consent. The local Medical Ethical 
Committee provided full approval for the study protocol under 
number 14439. US National Institutes of Health clinical trial regis-
tration was done at www.clinicaltrials.gov (number NCT01275014).
randomization
A parallel double-blind RCT was used as study design. Twenty-
five notes with the words “isotonic saline” and 25 notes with the 
word “dexamethasone” were printed and were put into 50 iden-
tical and non-transparent envelopes according to a random 
sequence, which was generated by an independent co-worker 
using a randomization software package (Statsdirect version 
2.7.7, StatsDirect Ltd., Cheshire, UK). Each envelope contained 
one note, and all envelopes were irreversibly sealed, only to be 
opened by a third and independent person in a closed room, 
separated from the operating room, just 1 min prior to the 
arthrocentesis procedure (see below), thus ensuring allocation 
concealment. No one else was able to see the contents of the 
note, and the person who had read the note prepared a blank 
transparent syringe with either 1 cc of transparent dexametha-
sone or an equal amount of saline, according to the note´s infor-
mation, thus allocating the participant to the intended treatment 
group. A syringe containing dexamethasone appeared identical 
to a syringe containing saline, since both fluids are completely 
colorless and have identical viscosity. The syringe was then 
handed to the oral surgeon without information on its contents.
Immediately after the syringe was prepared, the note was 
destroyed, and its contents were not communicated to anyone. 
At the end of the study, the remainder of the notes were 
destroyed.
In the control group, four men and 10 women were included; 
the intervention group consisted of one man and 13 women (see 
Table 1 and Fig. 1).
Arthrocentesis Procedure
The arthrocentesis procedure was performed with the partici-
pants under local anesthesia and took place in a closed operating 
room under controlled conditions. After the points for needle 
insertion were marked, the first 18-gauge injection needle was 
inserted into the upper intra-articular space of the TMJ. Correct 
positioning of the needle was determined by saline injection and 
aspiration. Subsequently, a second 18-gauge needle was inserted 
into the upper joint space about 8 to 10 mm anterior of the first 
needle. We confirmed correct positioning of the second needle 
by allowing injected saline to leave the joint through the first 
needle. After the needles were positioned, one needle was con-
nected to a medical infusion system to allow isotonic saline 
(37°C) to enter the upper joint compartment passively. The other 
needle was connected to an outflow tube to allow the fluid to 
exit the joint. In about 15 min, approximately 300 mL saline 
passively flushed the joint. Thereafter, the inflow was stopped, 
and the prepared syringe (see ‘Randomization Procedure’) that 
contained either dexamethasone or saline was connected to the 
inflow needle. In this way, either 1 cc of dexamethasone or an 
equal amount of saline was washed through the joint in a 
blinded way. At the end of the procedure, the needles were 
removed from the joint, and after hemostasis by compression (if 
necessary), the skin overlying the TMJ was covered with a ster-
ile adhesive plaster.
All patients were then instructed to avoid TMJ loading by 
following a soft diet for at least 2 wks, then gradually advancing 
to more tough food. In addition, ibuprofen 600 mg 3dd was 
prescribed for the first 2 to 5 days to reduce any post-operative 
pain. All procedures were performed by one surgeon (BS).
Follow-up visits were scheduled after 1 (T1), 3 (T2), and 24 
(T3) wks.
Outcomes
The primary outcome variables were TMJ pain at rest and dur-
ing mandibular movements [measured on a 100-mm Visual 
Analogue Scale (VAS), limited by “no pain” and “worst pain 
imaginable”] and the maximal interincisal opening (MIO, mea-
sured in millimeters).
A secondary outcome variable was function impairment 
[assessed with the Mandibular Function Impairment Questionnaire 
(MFIQ)]. The MFIQ is a questionnaire assessing, on a five-point 
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scale, an individual’s discomfort while performing mandibular 
functions and during eating of food with different consistencies 
(range, of 0-68) (Stegenga et al., 1993a; Kropmans et al., 1999). 
The assessments of TMJ pain, MIO, and MFIQ were carried out 
on the day of the surgical procedure (T0), and at T1, T2, and T3, 
by one person (LS).
statistical Procedures
Data analysis was executed in such a way that the analyst (JHS) 
could not observe the control or the intervention group in the 
dataset. The statistical analysis used ‘generalized estimating 
equation’ (GEE) models. By the application of GEE, relation-
ships between and among variables at different time-points are 
analyzed simultaneously.
For all analyses, α = 0.05. All procedures were executed in Stata 
version 10.1 SE (Stata Corp., College Station, TX, USA). The 
sample consisted of 28 participants (β = 0.8; f = estimated 0.3).
rEsults
All patients had complete remission of the reported pain within 
10 min after the administration of local intra-articular anesthesia 
into the upper joint cavity. Over time, in both groups, the TMJ 
pain (mm VAS) declined, MIO improved, and the MFIQ score 
decreased (see Figs. 2a-2c). GEE models were created for the 
outcome variables TMJ pain, MIO, and MFIQ. For all analyses, 
the first predictor variable to be entered into the model was 
treatment group (placebo, as reference, vs. dexamethasone). The 
hypothesis of interest was whether the pattern of the progression 
of the outcome over time differed between treatment groups. 
Hence, the hypothesis involved testing the interaction between 
time and treatment group, i.e., a model of Y = β0 + β1*treatment_
group +β2*time + β3*time*treatment_group, with the hypothesis 
H0: β3 = 0 tested.
Table 2 shows the estimated regression coefficients (β) for 
the variables treatment group, time, and their interaction for 
these models. The analyses showed that the treatment group had 
no relationship with all outcome variables, and therefore, no 
other predictors, confounders, or effect modifiers were entered 
into the model.
The achieved post hoc power (1- β error probability) for TMJ 
pain was 0.09 (f = 0.11); for MIO, it was 0.09 (f = 0.11).
DIscussIOn
The main findings from this study were that the administration 
of dexamethasone following an arthrocentesis procedure did not 
appear to have a significant additional effect on overall pain 
reduction.
Strengths of the study were that this was a double-blind trial 
on the additional use of a steroid after arthrocentesis. Additional 
steroids in arthrocentesis are used in clinical settings, but evi-
dence for their use is lacking. The main weakness of the trial 
was its small sample size.
Because of the relatively few samples, a type II statistical 
error may be a typical explanation for this finding. A common 
way to reduce random error in, or increase the precision of, an 
estimate is to enlarge the size of the study. Yet, a problem in 
planning study size is determining how to balance the value of 
greater precision in study results against the greater costs. 
Solving the problem thus involves a cost-benefit analysis of 
expending greater effort or funds to gain greater precision. 
Greater precision has a value to the beneficiaries of the research, 
but the value is indeterminate, because the number of beneficia-
ries is always uncertain. If the study had more patients, it is 
theoretically possible that the results could change, since the 
next “set” of patients could have a different response and thus 
outcome. If so, the total number of participants needed to dem-
onstrate a clinical effect of dexamethasone becomes so large 
table 1. Description and Comparison of the Control and Intervention Group at Start of the Study
Control Group  
(placebo, n = 14)
Intervention Group  
(dexamethasone, n = 14)
Variable Mean (95%CI) Mean (95%CI)
Age, yrs 33.9 (27.0 - 40.9) 32.6 (23.7 - 41.6)
Pain on mandibular movement (mm VAS) 53.4 (43.3 - 63.4) 47.4 (34.4 - 60.3)
MFIQ 52.3 (47.7 - 56.8) 52.8 (47.1 - 58.5)
Max opening 35.1 (30.0 - 40.3) 39.1 (35.2 - 42.9)
SCL-90 Dutch [Arrindell & Ettema (2003)]
Anxiety 13.7 (10.2 - 17.4) 14.2 (11.4 - 17.1)
Agoraphobia 7.6 (6.5 - 8.8) 8.4 (7.2 - 9.7)
Depression 25.7 (17.4 - 34.1) 23.4 (17.1 - 29.6)
Somatization 19.5 (15.5 - 23.5) 19.7 (15.1 - 24.4)
Cognitive-performance deficits 15.7 (9.9 - 21.5) 13.8 (11.3 - 16.3)
Interpersonal sensitivity and mistrust 23.7 (19.5 - 28.9) 23.9 (20.4 - 27.3)
Acting-out hostility 7.0 (6.2 - 7.8) 7.2 (6.2 - 8.3)
Sleep difficulties 5.7 (4.1 - 7.3) 5.2 (3.4 – 7.0)
Other complaints 4.9 (2.1 - 7.7) 6.4 (3.7 - 9.0)
General psychological distress/psycho-neuroticism 122.8 (92.8 - 152.8) 122.3 (100.1 - 144.5)
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that the net effect (i.e., the additional effect of dexamethasone) 
is clinically of minor importance compared with the effect of 
arthrocentesis. Arthrocentesis by itself has been shown to 
improve MIO and to reduce pain over time when it is compared 
with other therapies (e.g., physical therapy, splint therapy; 
Stegenga et al., 1993b; Goudot et al., 2000; Schiffman et al., 
2007; Dıraçoglu et al., 2009). In our study, the effect of arthro-
centesis thus clearly overpowered any effect of dexamethasone. 
Thus, administering additional dexamethasone following arthro-
centesis of the TMJ will most probably result in an outcome 
similar to that achieved by arthrocentesis without additional 
dexamethasone.
Normally, the pressure-bearing articular surfaces of the TMJ 
are non-innervated and cannot produce sensory input or noci-
ception. Proprioceptive input needed for functional guidance 
comes from the proprioceptors located in the muscles and liga-
ments (Hannam and Sessle, 1994). TMJ arthralgia primarily 
originates from the joint ligaments (i.e., capsule and disc attach-
ments) and the subchondral bone. Ligamentous receptors are 
high-threshold mechanoreceptors that are stimulated when the 
ligament is stretched beyond its functional range. However, 
inflammatory mediators may lower the pain threshold, making 
nociceptors more sensitive to stimulation. As a result, stimula-
tion from normal functioning may initiate sensations of discom-
fort. Arthralgia usually exerts a protective inhibitory influence 
on biomechanical activity, due to altered proprioceptive sensory 
or nociceptive input to the central nervous system. Usually, a 
primary insult, whether (bio)mechanical, biochemical, inflam-
matory, or immunologic, disturbs the intra-articular balance 
between synthesis and degradation (Stegenga, 2001). Early 
Figure 1. Patient flow chart and disposition of the participants.
Figure 2. Plots of the the TMJ pain (mm VAS), maximal interincisal 
opening, and MFIQ over time. Baseline data can be found in Table 1. 
After 1 wk, the TMJ pain was reduced to 41.0 (28.4 – 53.6) mm VAS 
(95% CI) and 38.9 (21.9 – 55.8) mm VAS (95% CI) for, respectively, 
the control group and the dexamethasone (intervention) group (A). At 
3 wks, the VAS values of the TMJ pain were 30.0 (13.1 – 47.0) mm 
and 23.9 (13.1 – 34.6) mm, respectively. At 24 wks, the pain was 
stable at 30.9 (10.1 – 51.7) mm VAS and 16.0 (1.2 – 30.8) mm VAS, 
respectively. At that point (24 wks), the maximal interincisal opening 
(95% CI) was 39.1 (33.4 – 44.8) mm and 41.0 (36.2 – 45.9) mm 
for, respectively, the control group and the dexamethasone (intervention) 
group (b). The MFIQ (95% CI) at 24 wks was 44.6 (33.9 – 55.4) and 
37.4 (28.0 – 46.7) for, respectively, the control group and the 
dexamethasone (intervention) group (c). In the control group, four men 
and 10 women were included; the intervention group consisted of one 
man and 13 women (see Table 1). There were no statistically significant 
differences between the intervention group and the control group for all 
outcome variables (see Table 2).
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changes in the joint cannot be diagnosed validly by radiographic 
imaging, because early pathology may escape radiological detec-
tion (Milam, 2005). Radiographic imaging will reveal only the 
cases later in the disease, when remodeling or internal derange-
ments are shown. The objectives for managing the condition are 
to re-establish the balance between synthesis and breakdown and 
to optimize the circumstances for repair and healing. These objec-
tives can be achieved by controlling overloading, improving func-
tion, and reducing pain. As such, therapy focuses on reassurance, 
instructions, anti-inflammatory medication, and arthrocentesis to 
control the pain. By flushing the TMJ, as is done in arthrocentesis, 
the degradative components are cleared from the joint, and this 
may be the reason arthrocentesis by itself has a therapeutic effect 
in a reduction of pain.
Dexamethasone modifies the vascular response during the 
inflammatory process and inhibits both destructive enzymes and 
the actions of inflammatory cells (Smith et al., 2003). It has 
been suggested that this decrease in inflammatory potency of the 
synovial fluid would result in greater pain reduction, but this 
study showed that the effect of dexamethasone contributed in a 
minor way to that effect, if at all.
Because of small sample sizes, this study was also unable to 
identify any side-effects of dexamethasone. One uncertainty is 
the unknown working time of dexamethasone in the TMJ. Its 
half-life of 36 to 72 hrs makes it unlikely that long-term effects 
can be expected. Our analyses also did not suggest a long-term 
effect. However, these half-life effects do not count for all cor-
ticosteroids. Kenacort, for example, has a longer half-life and 
may have a longer lasting effect as compared with dexametha-
sone. Kenacort, however, is opaque white and is more difficult 
to test in a double-blind fashion. We tested an opaque syringe, 
but the problem was that droplets of Kenacort were regularly 
spilled while the syringe was being connected to the needles, 
thus revealing the contents. To our knowledge, no RCTs exist 
addressing the long-term effect of Kenacort.
In conclusion, intra-articular dexamethasone following an 
arthrocentesis procedure did not improve the effect of the 
arthrocentesis in patients presenting with TMJ arthralgia.
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